| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/27/2007 | CN1323079C Renin inhibitors |
| 06/27/2007 | CN1323060C MPTP affinity labels |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/27/2007 | CN1322868C Blood vessel care solution |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235665 Process for the production of piperidine derivatives |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235637 IL-1 eta DNA and polypeptides |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235588 Administering tyrphostin janus associated kinase inhibitor |
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235538 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/26/2007 | US7235403 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng |
| 06/26/2007 | US7235260 Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor |
| 06/26/2007 | US7235259 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 06/26/2007 | US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
| 06/26/2007 | CA2455231C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2290739C New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/21/2007 | WO2007069932A1 Method for suppressing appetite and food intake |
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative |
| 06/21/2007 | WO2007069758A1 Composition having ppar ligand activity |
| 06/21/2007 | WO2007069744A1 Composition for prevention/amelioration of metabolic syndrome |
| 06/21/2007 | WO2007069671A1 Bicyclic heterocyclic compound |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069621A1 Novel composition and method for production thereof |
| 06/21/2007 | WO2007069603A1 Physiologically active glycolipid |
| 06/21/2007 | WO2007069565A1 Bicyclic heterocyclic compound |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142466 Photoreactive compounds and compositions |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142419 Thienyl Compounds |
| 06/21/2007 | US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142388 Inhibitors of Akt activity |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
| 06/21/2007 | US20070142266 Combination comprising a P-gp inhibitor and an anti-epileptic drug |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070141621 Method Of Screening For Sensitivity To Kinase Inhibitor Therapy |
| 06/21/2007 | US20070141619 Drug resistance-associated gene and use thereof |
| 06/21/2007 | US20070141173 Medicament comprising noble metal fine particles |
| 06/21/2007 | US20070141088 Glucan-based vaccines |
| 06/21/2007 | US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 06/21/2007 | US20070141038 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site |
| 06/21/2007 | US20070141000 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 06/21/2007 | DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor |
| 06/20/2007 | EP1798290A1 Tryptophan amino transferases, indol-3-pyruvate decarboxylases and indol-3-acetal dehydoxidases as new targets for herbicides |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798227A1 Serotonin 5-ht3 receptor agonist |
| 06/20/2007 | EP1798226A1 Triazole derivative |
| 06/20/2007 | EP1798225A1 Nucleoside analogues or salts thereof |
| 06/20/2007 | EP1798217A1 Anticancer agents based on regulation of protein prenylation |
| 06/20/2007 | EP1797902A2 Particles for inhalation having sustained release properties |
| 06/20/2007 | EP1797897A1 Medicinal composition containing meltrin antagonist |
| 06/20/2007 | EP1797884A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/20/2007 | EP1797881A1 Medicinal composition |
| 06/20/2007 | EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 06/20/2007 | EP1455770B1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 06/20/2007 | EP1414457B1 Chiral dinapsoline |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2007 | EP1373253B1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | EP1228231B1 Mammalian-type glycosylation in plants |
| 06/20/2007 | EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/20/2007 | CN1984900A Indole derivatives having piperidine rings |